Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ·Healthcare·Biotechnology
$4.12
-3.06%
Mkt Cap $301.46M
Analyst Ratings
Buy
2
Hold
1
Sell
0
Price Target (12 analysts)
$2.00
Range $2.00 – $2.00
Implied Upside
-51.5%
Consensus $2.00 vs current $4.12
NASDAQ·Healthcare·Biotechnology
$4.12
-3.06%
Mkt Cap $301.46M
Buy
2
Hold
1
Sell
0
Price Target (12 analysts)
$2.00
Range $2.00 – $2.00
-51.5%
Consensus $2.00 vs current $4.12